The patients’ putative class action case addressed surgeries done between 1996 and 2006.
The case was dismissed in the lower courts. The circuit court’s March 25 ruling upheld the decision to dismiss based on the grounds that the case conflicts with FDA authority and federal law overseeing medical devices.
More Articles on Ophthalmology:
5 Recent Ophthalmology-Driven Facility Openings & Expansions
National Eye Institute Funds $6.2M Macular Degeneration Study
Dr. Michael Manning Partners With Suncoast Eye Clinic
